There were 154 press releases posted in the last 24 hours and 404,465 in the last 365 days.

Penetran Products Completes Distribution Agreement With AmerisourceBergen

WEST PALM BEACH, FL, USA, August 11, 2015 /EINPresswire.com/ -- Penetran Products, an over the counter pharmaceutical company focusing on the commercialization and promotion of it’s topical pain relief lotion PenetranPlus®, announces that it has signed a nationwide distribution agreement with AmerisourceBergen, one of the largest global pharmaceutical sourcing and distribution services companies.

Under the agreement, AmerisourceBergen will carry and distribute PenetranPlus to independent and retail chain pharmacies across the U.S. Combined with Penetran Products’ previous distribution agreements with McKesson Corporation (MCK) and Cardinal Health (CAH) PenetranPlus will now be available to the majority of the nation’s 60,000 pharmacies across the country.

“Our agreement with AmerisourceBergen represents yet another major achievement in our commercial strategy,” said Rod Jackson, Chairman and CEO of Penetran Products. “Patients who can benefit from PenetranPlus topical pain relief lotion are now assured that the product will be available through almost every pharmacy in America.”

Penetran Products is a South Florida based pharmaceutical company that focuses on delivering clinically proven, unique, and patented products to the wholesale, retail, and consumer markets. Penetran Products’ leading line is PenetranPlus a unique over-the-counter topical pain relief lotion. Penetran Products also promotes Ocean Blue™ 2100 - a highly purified, effective, and clinically proven behind-the-counter omega product. Ocean Blue is a registered trademark of Sancilio & Company, Inc.

Paul Davis
Penetran Products
704-421-8353
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.